Latest Recruitment News

Cyclopharm has launched a pioneering clinical study combining its Technegas imaging with AI analysis to explore a novel treatment for severe COPD, potentially expanding care options for millions.

Aurelia Metals announces Managing Director Bryan Quinn will resign by July 2026, with a leadership search underway amid key project developments.

Emyria Limited has reported strong quarterly revenue growth driven by the expansion of its Empax clinic network across multiple Australian states, supported by a recent $8 million institutional placement to fund its national rollout and workforce expansion.

Boss Energy delivered a record uranium production quarter at its Honeymoon project, lowering cost guidance and initiating a new feasibility study to reshape its mining strategy.

Minerals 260 Limited has significantly expanded its Bullabulling Gold Project resource to 4.5 million ounces, nearly doubling its previous estimate, while advancing key development milestones ahead of a mid-2026 Pre-Feasibility Study completion.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

EMVision Medical Devices reports strong clinical trial progress for its portable brain scanners, backed by solid cash reserves and milestone grant funding.

Austral Resources Australia Ltd has emerged strongly from a 26-month ASX suspension, delivering robust copper production and sales that beat expectations in the December 2025 quarter. The company’s strategic acquisitions and exploration efforts position it for growth in 2026.

EMVision Medical Devices reports strong progress in its emu™ Brain Scanner clinical trials, expanding recruitment across seven leading stroke hospitals and introducing new software features to enhance scan quality.

EDU Holdings Limited anticipates FY25 financial results near the top of its guidance, driven by strong revenue and profit growth from its higher education arm, Ikon Institute.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.